RxDoctor Payments Data

Amy Tang

Pediatric Hematology-Oncology · Atlanta, GANPI 1194016428

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Pfizer at 34.6% of the total. Reporting peaked in 2023 at $6,194 and has fallen 95.2% since, to $300 in 2025.

$18,286in general payments, 2019–2025

Across 33 payments — averaging $554.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$6K
  • Global Blood Therapeutics, Inc.$6K
  • Novartis$5K
  • Chiesi USA, Inc.$358
  • Novo Nordisk$249
  • AstraZeneca$150
  • plus $153 from 2 others
$800,585in research payments, 2019–2025

Across 10 payments — averaging $80,059 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$765K
  • Novo Nordisk AS$36K

What the payments were for

  • Consulting fees$6,24434%
  • Speaking & faculty fees$8,16545%
  • Travel & lodging$2,25012%
  • Food & beverage$1,6269%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer9$6,328
Global Blood Therapeutics, Inc.5$6,327
Novartis12$4,720
Chiesi USA, Inc.2$358
Novo Nordisk2$249
AstraZeneca1$150
Agios Pharmaceuticals, Inc.1$132
Medunik USA Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,286 in reported general payments places this provider in the 75th percentile of 74 pediatric hematology-oncology providers in Georgia.

See all pediatric hematology-oncology providers in Georgia

Other pediatric hematology-oncology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →